Peroxisome proliferator-activated receptor γ gene locus is related to body mass index and lipid values in healthy nonobese subjects

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 12, 1999, Pages 2940-2944

  Knoblauch, Hans ^a   Busjahn, Andreas ^a   Müller Myhsok, Bertram ^b   Faulhaber, Hans Dieter ^a   Schuster, Herbert ^a   Uhlmann, Regina ^a   Luft, Friedrich C ^a,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c FRANZ VOLHARD CLINIC   (Germany)

Author keywords

Body mass index; Cholesterol, HDL; Cholesterol, LDL; Genetics; PPAR ; Quantitative trait loci; Twins

Indexed keywords

CARBOHYDRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOID X RECEPTOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; MORBID OBESITY; NORMAL HUMAN; PRIORITY JOURNAL; TWINS;

EID: 0033387971     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.12.2940     Document Type: Article

References (38)

1. Forman BM, Umensono K, Chen J, Evans RM. Unique response pathways are established by allosteric interactions among nuclear receptors. Cell. 1995;81:541-550.
2. Kliewer SA, Umensono K, Mangelsdorf FJ, Evans RM. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone, and vitamin D3 signaling. Nature. 1992;355:446-449.
3. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Wilson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem. 1995;270:12953-12956.
4. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 1992;68:879-887.
5. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994;79:1147-1156.
6. Tontonoz P, Nagy L, Alvarez JGA, Thomazy VA, Evans RM. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 1998;93:241-252.
7. Ristow M, Müller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med. 1998;339:953-959.
8. Busjahn A, Faulhaber H-D, Viken RJ, Rose RJ, Luft FC. Genetic influences on blood pressure with the cold pressor test: a twin study. J Hypertens. 1996;14:1195-1199.
9. Busjahn A, Knoblauch H, Knoblauch M, Schuster H, Bohlender J, Faulhaber H-D, Luft FC. Angiotensin converting enzyme and angiotensinogen gene polymorphisms, plasma levels, and left ventricular size: a twin study. Hypertension. 1997;29:165-170.
10. Becker A, Busjahn A, Faulhaber H-D, Bähring S, Schuster H, Luft FC. Automated zygosity determination with microsatellites. J Reprod Med. 1997;42:260-266.
11. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
12. Friedewald WT, Lewy RI, Fredrickson DS. Estimation of plasma low-density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-501.
13. Beamer BA, Negri C, Yen CJ, Gavrilova O, Rumberger JM, Durcan MJ, Yarnall DP, Hawkins AL, Griffin CA, Burns DK, Roth J, Reitman M, Shuldiner AR. Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene. Biochem Biophys Res Commun. 1997;233:756-759.
14. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J, Amouyel P. A genetic polymorphism of the peroxisome proliferator activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet. 1998;7:435-440.
15. Eaves LJ, Neale MC, Maes H. Multivariate multipoint linkage analysis of quantitative trait loci. Behav Genet. 1996;26:519-525.
16. Neale MC. Mx: Statistical Modeling. 4th ed. Richmond, Va: Department of Psychiatry; 1997.
17. Kruglyak L, Lander ES. Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet. 1995;57:439-454.
18. Fulker DW, Cherny SS. An improved multipoint sib-pair analysis of quantitative traits. Behav Genet. 1996;26:527-532.
19. Lander ES, Kruglyak L. Genetic dissection of complex traits: guideline: for interpreting and reporting linkage results. Nat Genet. 1995;11: 241-246.
20. Miller MB. Monozygotic twins increase power of genetic association studies of complex phenotypes. Behav Genet. 1998;28:1024. Abstract.
21. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269-1276.
22. Knoblauch H, Busjahn A, Münter S, Nagy Z, Faulhaber H-D, Schuster H, Luft FC. Heritability analysis of lipids and three gene loci in twins link the macrophage scavenger receptor to HDL cholesterol concentrations. Arterioscler Thromb Vasc Biol. 1997;17:2054-2060.
23. Lee JH, Reed DR, Li WD, Xu WZ, Joo EJ, Kilker RL, Nanthakumar E, North M, Sukul H, Bell C, Price RA. Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet. 1999;64:196-209.
24. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D, Foroud T, Kobes S, Baier L, Burns DK, Almasy L, Blangero J, Garvey WT, Bennett PH, Knowler WC. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet. 1998;63:1130-1138.
25. Borecki IB, Blangero J, Rice T, Perusse L, Bouchard C, Rao DC. Evidence for at least two major loci influencing human fatness. Am J Hum Genet. 1998;63:831-838.
26. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med. 1997;337: 396-407.
27. Criqui MH, Golomb BA. Epidemiologic aspects of lipid abnormalities. Am J Med. 1998;105:48S-57S.
28. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci U S A. 1997;94:4312-4317.
29. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM. Fatty acids and eicosanoids regulate gene expression through direct interaction with peroxisome proliferator-activated receptors α and γ. Proc Natl Acad Sci U S A. 1997;94:4318-4323.
30. Krey G, Braissant O, LâHorset F, Kalkhoven E, Perroud M, Parker MG, Wahli W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Endocrinology. 1997;11:779-791.
31. Spiegelman BM. PPARγ in monocytes: less pain, any gain? Cell. 1998; 93:153-155.
32. Mukherjee R, Strasser J, Jow L, Hoener P. Paterniti JR, Heyman RA. RXR agonists activate PPARα-inducible genes, lower triglycerides, and raise HDL levels in vivo. Arterioscler Thromb Vasc Biol. 1998;18: 272-276.
33. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature. 1998;391:79-86.
34. Nagy L, Tontonoz P, Alvarez JGA, Chen HW, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR gamma. Cell. 1998;93:229-240.
35. Dwyer JT, Stone EJ, Yang M, Feldman H, Webber LS, Must A, Perry CL, Nader PR, Parcel GS. Predictors of overweight and overfatness in a multiethnic pediatric population: Child and Adolescent Trial for Cardiovascular Health Collaborative Research Group. Am J Clin Nutr. 1998;67: 602-610.
36. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkännen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J. A Pro 12A1a substitution in PPARγ associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998;20:284-287.
37. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR. Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ 2 missense mutation. Biochem Biophy Res Commun. 1997;241:270-274.
38. Ringel J, Engeli S, Distler A, Sharma AM. Pro12Ala missense mutation of the peroxisome proliferator activated receptor γ and diabetes mellitus. Biochem Biophys Res Commun. 1999;254:450-453.